Dhofar Pharmaceutical Industries Company has inaugurated a new pharmaceutical plant in Raysut Industrial City, Wilayat of Salalah.
Valued at RO 15 million, this facility is designed to bolster drug security in Oman, specializing in intravenous and kidney dialysis solutions using cutting-edge German technology and adhering to international quality standards. Spanning approximately 22,000 square meters, it aims to fulfill the local and regional market needs, with an annual production capacity of 15 million intravenous units and 2.3 million kidney dialysis units.
The Minister of Commerce highlighted that the plant is a product of the Health Sector Investment Lab, a collaborative effort with the Ministry of Health, National Program for Investment and Exports Development (Nazdaher), and Oman 2040 Vision Implementation Follow-up Unit. He emphasized that this initiative supports Oman Vision 2040’s objectives in industry and health security.
Shaikh Salim bin Ali al Mahri, Chairman of Dhofar Pharmaceutical Industries Company, noted that this pioneering project is poised to meet Oman’s annual demand for intravenous and dialysis solutions, estimated at 5 million units.
